The mission of Roswell Park Cancer Institute (RPCI) CCSG Administration is to foster research, collaboration, and scientific productivity of CCSG members. During the award period, staff members have supported: 1) achieving a 17% increase in peer-reviewed, cancer grant funding;2) adding 3 new shared resources and consolidation of two existing Shared Resource services;3) adding 137 new clinical and research faculty (including 51 new CCSG members);4) planning for a new 142,000 square foot (sf) clinical, research, and office building;5) awarding more than $9.5 million in CCSG and RPCI developmental research funds;6) supporting planning and evaluation activities for the research programs. Shared Resources, and other initiatives;7) implementing more rigorous CCSG membership criteria which led to increased focus with reduced membership from 149 in 2008 to 138;8) implementing Laboratory Information Management Systems in five Shared Resources;9) developing new electronic research tools to foster grant development;and 10) implementing an Inclusion Council to foster collaboration and coordination among outreach efforts, research programs, and Shared Resources. Administration supports the Director in new faculty recruitment;administrative leadership of the planning and evaluation process;administrative oversight of Research Programs and shared resources;development and management of computer databases and other information systems tools;fiscal management and consultation;space and equipment management;providing support for selection, award, and monitoring of pilot research funding;administration of the membership and review process;coordination of research seminars, workshops, and retreats;leadership or assistance in developing collaborations between and among investigators for new research initiatives;planning, coordination, and execution of multi-project research grants (e.g., SPOREs, PPGs);and targeted communication of cancer-related funding opportunities and research tools to CCSG members. Administration includes 4.5 FTE within the CCSG administrative unit, which is leveraged by an additional 27 FTE of administrative and information technology support staff. Administration makes up 1.4% of the total RPCI research budget and 5.6% of the requested CCSG budget.

Public Health Relevance

RPCI Administration manages and facilitates the research of the only NCI Comprehensive Cancer Center in upstate New York, with the goal to foster cutting edge, transdisciplinary science to understand, prevent, and cure cancer. RPCI Administration supports six research programs, 14 shared resources, membership, planning evaluation, and research development activities.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016056-37
Application #
8738381
Study Section
Subcommittee G - Education (NCI)
Project Start
1997-06-16
Project End
2019-04-30
Budget Start
2014-06-26
Budget End
2015-04-30
Support Year
37
Fiscal Year
2014
Total Cost
$218,391
Indirect Cost
$86,382
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
824771034
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Dasgupta, Subhamoy; Rajapakshe, Kimal; Zhu, Bokai et al. (2018) Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer. Nature 556:249-254
La Shu, Shin; Yang, Yunchen; Allen, Cheryl L et al. (2018) Metabolic reprogramming of stromal fibroblasts by melanoma exosome microRNA favours a pre-metastatic microenvironment. Sci Rep 8:12905
Mayor, Paul C; Eng, Kevin H; Singel, Kelly L et al. (2018) Cancer in primary immunodeficiency diseases: Cancer incidence in the United States Immune Deficiency Network Registry. J Allergy Clin Immunol 141:1028-1035
Gabriel, Emmanuel; Attwood, Kristopher; Al-Sukhni, Eisar et al. (2018) Age-related rates of colorectal cancer and the factors associated with overall survival. J Gastrointest Oncol 9:96-110
Ma, Wen Wee; Xie, Hao; Fetterly, Gerald et al. (2018) A Phase Ib Study of the FGFR/VEGFR Inhibitor Dovitinib With Gemcitabine and Capecitabine in Advanced Solid Tumor and Pancreatic Cancer Patients. Am J Clin Oncol :
Zhang, Dingxiao; Tang, Dean G; Rycaj, Kiera (2018) Cancer stem cells: Regulation programs, immunological properties and immunotherapy. Semin Cancer Biol 52:94-106
Eng, Kevin H; Szender, J Brian; Etter, John Lewis et al. (2018) Paternal lineage early onset hereditary ovarian cancers: A Familial Ovarian Cancer Registry study. PLoS Genet 14:e1007194
Barger, Carter J; Zhang, Wa; Sharma, Ashok et al. (2018) Expression of the POTE gene family in human ovarian cancer. Sci Rep 8:17136
Chen, George L; Carpenter, Paul A; Broady, Raewyn et al. (2018) Anti-Platelet-Derived Growth Factor Receptor Alpha Chain Antibodies Predict for Response to Nilotinib in Steroid-Refractory or -Dependent Chronic Graft-Versus-Host Disease. Biol Blood Marrow Transplant 24:373-380
Leonova, Katerina; Safina, Alfiya; Nesher, Elimelech et al. (2018) TRAIN (Transcription of Repeats Activates INterferon) in response to chromatin destabilization induced by small molecules in mammalian cells. Elife 7:

Showing the most recent 10 out of 1555 publications